This post was written by Paul Sheives.

FDA will hold a public meeting entitled“Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors” on June 24-25, 2010 in Bethesda, Maryland. The meeting is intended to seek input from interested parties about the design of drug and therapeutic biologic container labels, carton labeling, and product packaging, and practices to develop proprietary names to reduce medication errors. Based on the information received at the meeting, and through the submission of written comments, FDA will develop a draft guidance for industry on this subject. Written comments are due by June 23, 2010.